Portfolio Design Labs’s ResMed RMD Stock Holding History

Portfolio Design Labs’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-982	Closed	-$220K	–	240
2026 Q1	$220K	Buy	+982	New	+$245K	0.04%	220
2024 Q1	–	Sell	-1,651	Closed	-$284K	–	141
2023 Q4	$284K	Buy	+1,651	New	+$254K	0.11%	99

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Portfolio Design Labs's RMD Position: Q2 2026 in Review

Portfolio Design Labs sold out of ResMed (RMD) in Q2 2026, closing a stake of 982 shares — an estimated $220K sold.

Portfolio Design Labs first reported a position in RMD in Q4 2023 and held it in 2 quarters. The position peaked at $284K in Q4 2023. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Portfolio Design Labs reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
Portfolio Design Labs sold 982 ResMed shares in Q2 2026, an estimated $220K.
Portfolio Design Labs first reported a position in ResMed in Q4 2023 and held it in 2 quarters.
Portfolio Design Labs's ResMed position peaked at $284K in Q4 2023.
887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Portfolio Design Labs's 13F filing for Q2 2026, filed 11 Aug 2026.